Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD
Clinical trial NCT03247530 · COMPLETED
Trial details
- NCT number
- NCT03247530
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-20
- Primary completion
- 2018-09-12
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.